Skip to main content
. Author manuscript; available in PMC: 2017 Sep 21.
Published in final edited form as: Eur J Cancer. 2008 Aug 22;44(15):2259–2265. doi: 10.1016/j.ejca.2008.07.010

Table 2. Genotype frequencies and results of univariate Cox regression analysis of common polymorphisms and invasive ovarian cancer survival with P < 0.2.

Gene Rs numbera Genotype frequencies
Trend testc
Hazard ratio per-rare alleled
AAb Aa aa Total χ 2 P-value HR LCL UCL
MLH1 rs1800734 822 418 66 1306 3.18 0.07 0.87 0.75 1.02
rs1799977 510 417 97 1024 3.77 0.05 1.2 1.00 1.4
rs2286939 397 663 265 1325 2.81 0.09 1.1 0.98 1.3
MSH6 rs2348244 936 325 25 1286 1.89 0.17 0.88 0.72 1.06
MSH2 rs3771274 467 637 207 1311 1.64 0.20 1.09 0.96 1.2
MSH3 rs40139 416 667 239 1322 3.71 0.05 0.88 0.78 1.00
rs26282 697 519 99 1315 1.73 0.19 1.1 0.96 1.3
rs33008 156 647 451 1254 1.99 0.16 0.90 0.79 1.04
rs2897298a 779 244 19 1042 1.72 0.19 1.1 0.95 1.3
PMS2 rs2228006a 1068 372 33 1473 4.29 0.04 0.84 0.71 0.99
a

SNPs were genotyped in new batch of DNA samples containing 446 cases for MALOVA study, the rest of the SNPs in the table were genotyped in the subset of the MALOVA study (278 cases).

b

AA, common homozygote; Aa, heterozygote; aa, rare homozygotes.

c

Stratified by study.

d

Hazard ratio with 95% confidence interval.